GlassScriptPhysician profile
Allison S Hunt
NPI 1922201516
$3,041.74
in general payments reported to CMS, 2019-2025
39 companies · $302 in 2025
The $302 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $509 · 2020: $163 · 2021: $492 · 2022: $799 · 2023: $475 · 2024: $302 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,079.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,078.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $619.45 | 2019-2023 | |
| Daiichi Sankyo INC. | $284.18 | 2023-2025 | Injectafer |
| Abbvie INC. | $273.14 | 2019-2023 | |
| Pfizer INC. | $222.25 | 2019-2023 | |
| Medtronic, INC. | $157.29 | 2022-2025 | Truclear |
| Organon LLC | $140.12 | 2021-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $116.20 | 2019-2023 | Affirm Prone Biopsy System |
| Therapeuticsmd, INC. | $115.85 | 2019-2022 | |
| Avion Pharmaceuticals | $107.72 | 2019-2021 | |
| Exeltis, USA INC. | $98.26 | 2020-2025 | Slynd |
| Coopersurgical, INC. | $92.67 | 2021-2024 | Paragard T 380a |
| Astellas Pharma US INC | $78.37 | 2023-2025 | Veozah |
| Allergan, INC. | $71.30 | 2019 | |
| Evofem Biosciences, INC. | $63.33 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $61.78 | 2023-2024 | Myfembree |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $60.86 | 2021-2023 | |
| Smith+Nephew, INC. | $48.35 | 2023 | Stravix Pl |
| Myovant Sciences INC. | $37.51 | 2021-2022 | |
| Davol INC. | $28.25 | 2022 | |
| Convatec INC. | $27.85 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $27.51 | 2021 | |
| Alexion Pharmaceuticals, INC. | $22.99 | 2022 | |
| Abbott Laboratories | $21.82 | 2022 | |
| Dexcom, INC. | $21.51 | 2025 | Dexcom G6 Transmitter |
| Tesaro, INC. | $20.45 | 2019 | |
| Amag Pharmaceuticals, INC. | $19.92 | 2019 | |
| Aroa Biosurgery Incorporated | $19.52 | 2023 | |
| Aspira Women'S Health INC | $18.29 | 2022 | |
| Scynexis, INC. | $17.65 | 2022 | |
| Heron Therapeutics, INC. | $17.58 | 2024 | Zynrelef |
| Vertical Pharmaceuticals, LLC | $16.97 | 2019 | |
| Exact Sciences Corporation | $16.35 | 2025 | Cologuard Collection Kit |
| Sage Therapeutics, LLC | $15.49 | 2024 | |
| Biotissue Holdings INC. | $15.00 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $14.15 | 2019 | |
| Renovia INC | $13.86 | 2019 | |
| Vapotherm INC | $13.19 | 2024 | Vapotherm |
| Ethicon US, LLC | $12.64 | 2021 | |
| Lupin INC. | $12.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Hunt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.